Assyro AI

Orange Book product · Generic (ANDA)

DEFEROXAMINE MESYLATE

DEFEROXAMINE MESYLATE

Generic (ANDA)ANDA 078718TE APRX FRESENIUS KABI USA

At a glance

Sep 15, 2009

Approved

Generic (ANDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Sep 15, 2009

    17 yr ago

  2. Today

Pharmaceutical detail

Active ingredient

DEFEROXAMINE MESYLATE

Strength

2GM/VIAL

Dosage form

INJECTABLE

Route

INJECTION

TE code

AP

Application

ANDA 078718

Product number

002

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of DEFEROXAMINE MESYLATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.